UA120761U - MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION - Google Patents
MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTIONInfo
- Publication number
- UA120761U UA120761U UAU201708003U UAU201708003U UA120761U UA 120761 U UA120761 U UA 120761U UA U201708003 U UAU201708003 U UA U201708003U UA U201708003 U UAU201708003 U UA U201708003U UA 120761 U UA120761 U UA 120761U
- Authority
- UA
- Ukraine
- Prior art keywords
- spasmolitic
- morphin
- action
- medicinal product
- compound
- Prior art date
Links
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title abstract 4
- 229960005181 morphine Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000002048 spasmolytic effect Effects 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 4
- 239000003708 ampul Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- -1 dilute Chemical compound 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008215 water for injection Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Лікарський препарат знеболювальної дії, який включає сполуку за формулою І: EMBED ISISServer (І) або її фармацевтично прийнятну сіль, причому сполука за формулою І є морфін, а як фармацевтично прийнятну сіль використовують сульфат або гідрохлорид, лікарський препарат застосовується у формі розчину для ін'єкцій по 10 мг/мл по 1 мл в ампулі, причому кожна ампула включає 10 мг розчину сполуки за формулою І або її гідрохлориду, де ампула виготовлена з хімічно стійкого матеріалу, допоміжні речовини вибирають як щонайменше одну речовину з ряду взаємозамінюваних речовин: кислота хлористоводнева розведена, вода для ін'єкцій, натрію хлорид.An analgesic drug comprising a compound of formula I: EMBED ISISServer (I) or a pharmaceutically acceptable salt thereof, wherein the compound of formula I is morphine, and sulfate or hydrochloride is used as a pharmaceutically acceptable salt, the drug being used in the form of a solution injection of 10 mg / ml of 1 ml in the ampoule, each ampoule includes 10 mg of a solution of the compound of formula I or its hydrochloride, where the ampoule is made of a chemically stable material, excipients are selected as at least one substance in a series of substitutions substances: hydrochloric acid, dilute, water for injection, sodium chloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708003U UA120761U (en) | 2017-08-01 | 2017-08-01 | MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708003U UA120761U (en) | 2017-08-01 | 2017-08-01 | MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA120761U true UA120761U (en) | 2017-11-10 |
Family
ID=60258607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201708003U UA120761U (en) | 2017-08-01 | 2017-08-01 | MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA120761U (en) |
-
2017
- 2017-08-01 UA UAU201708003U patent/UA120761U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201690069A1 (en) | THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE | |
| SA520411119B1 (en) | Liposomal formulations include weak acid-based drugs and their uses | |
| PE20151592A1 (en) | MOSAPRIDE SUSTAINED RELEASE FORMULATION THAT PROVIDES PHARMACOLOGICAL AND CLINICAL EFFECTS WITH ONCE DAILY ADMINISTRATION | |
| CY1111159T1 (en) | CONCENTRATED Methotrexate Solutions | |
| CY1122387T1 (en) | DUAL USE TABLETS OF ORAL PHARMACEUTICAL COMPOSITION OF SULFATE SALTS AND METHODS OF USING THEREOF | |
| RU2019134416A (en) | PHARMACEUTICAL COMPOSITIONS | |
| MX2021015827A (en) | NEUROKININ ANTAGONIST -1. | |
| CY1118158T1 (en) | SECONDARY 1-Piperazine-3-phenyl indians for the therapeutic treatment of schizophrenia | |
| EA200600377A1 (en) | NEW COMPOSITION | |
| EA201691693A2 (en) | COMBINED MEDICINE PREPARATION IN THE FORM OF SPELLING TABLETS AND METHOD OF ITS PREPARATION | |
| PH12022550917A1 (en) | Use of phenylquinolinones and flavonoid derivatives for treating neuropathic pain | |
| UA120764U (en) | THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" | |
| RU2016145411A (en) | The combination of brexpiprazole and nalmefene, and its use for the treatment of the syndrome of chemical dependence | |
| RU2014148062A (en) | INJECTION PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL | |
| EA201991359A1 (en) | PHARMACEUTICAL MEDICINAL FORMS | |
| DK2091520T3 (en) | ORAL DOSAGE FORM CONTAINING TRISUBSTITUTED GLYCEROL COMPOUNDS | |
| RU2015128024A (en) | PHARMACEUTICAL COMPOSITION BASED ON CHLOROPROCAYINE FOR REPEATED INTRA-THECAL INTRODUCTION | |
| UA120763U (en) | MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" | |
| RU2013127881A (en) | APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment | |
| UA144735U (en) | METHOD OF TREATMENT OF DIGESTIVE DISEASES | |
| UA124849U (en) | METHOD OF TREATMENT OF MEDICAMENTOUS TOXIC HEPATITIS IN PATIENTS WITH TUBERCULOSIS OF THE LUNGS AFTER THE postoperative period | |
| RU2003108517A (en) | METHOD FOR TREATING COLIBACTERIOSIS AND SALMONELLOSIS IN PIGLIES | |
| Morteza Talebi et al. | Pain management in emergency department: intravenous morphine vs. intravenous acetaminophen | |
| TH123637A (en) | Powder formulation for Vulganciclorver | |
| TH167687A (en) | Medicine to prevent or treat constipation |